APO RESEARCH · REPORT
Buprenorphine Hydrochloride
Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
Product & engineering
Understand the product.
Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
Selected research
Market Structure
Global Buprenorphine Hydrochloride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
Europe is the largest market with about 31% market share. Middle East& Africa and Asia-Pacific are follower.
The main manufacturers are Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichemlabs, Arevipharma, Resonance-labs, Sun Pharma, Rusan Pharma, Micro Orgo Chem, Faranshimi etc. Siegfried is the largest manufacturer with about 23% market share.
Read the full market overview
This report provides an overview of the global Buprenorphine Hydrochloride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Buprenorphine Hydrochloride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Buprenorphine Hydrochloride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Buprenorphine Hydrochloride market size, projected growth trends, production technologies, key applications, and end-use industries.
Buprenorphine Hydrochloride Segment by Company
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi
Buprenorphine Hydrochloride Segment by Type
Tablets
Injection
Buprenorphine Hydrochloride Segment by Application
Analgesic
Opioid Antagonist
Buprenorphine Hydrochloride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buprenorphine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Buprenorphine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buprenorphine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Buprenorphine Hydrochloride market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Buprenorphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Buprenorphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Buprenorphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Injection
Applications
- Analgesic
- Opioid Antagonist
Companies covered
- Siegfried
- Sanofi
- Johnson Matthey
- Mallinckrodt
- Noramco
- Unichemlabs
- Arevipharma
- Resonance-labs
- Sun Pharma
- Rusan Pharma
- Micro Orgo Chem
- Faranshimi
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Buprenorphine Hydrochloride Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Buprenorphine Hydrochloride Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Buprenorphine Hydrochloride Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Buprenorphine Hydrochloride Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Buprenorphine Hydrochloride Market Dynamics
- 2.1 Buprenorphine Hydrochloride Industry Trends
- 2.2 Buprenorphine Hydrochloride Industry Drivers
- 2.3 Buprenorphine Hydrochloride Industry Opportunities and Challenges
- 2.4 Buprenorphine Hydrochloride Industry Restraints
3 Buprenorphine Hydrochloride Market by Manufacturers
- 3.1 Global Buprenorphine Hydrochloride Revenue by Manufacturers (2021-2026)
- 3.2 Global Buprenorphine Hydrochloride Sales by Manufacturers (2021-2026)
- 3.3 Global Buprenorphine Hydrochloride Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Buprenorphine Hydrochloride Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Buprenorphine Hydrochloride Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Buprenorphine Hydrochloride Manufacturers, Product Type & Application
- 3.7 Global Buprenorphine Hydrochloride Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Buprenorphine Hydrochloride Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Buprenorphine Hydrochloride Players Market Share by Revenue in 2025
- 3.8.3 2025 Buprenorphine Hydrochloride Tier 1, Tier 2, and Tier 3
4 Buprenorphine Hydrochloride Market by Type
- 4.1 Buprenorphine Hydrochloride Type Introduction
- 4.1.1 Tablets
- 4.1.2 Injection
- 4.2 Global Buprenorphine Hydrochloride Sales by Type
- 4.2.1 Global Buprenorphine Hydrochloride Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Buprenorphine Hydrochloride Sales by Type (2021-2032)
- 4.2.3 Global Buprenorphine Hydrochloride Sales Market Share by Type (2021-2032)
- 4.3 Global Buprenorphine Hydrochloride Revenue by Type
- 4.3.1 Global Buprenorphine Hydrochloride Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Buprenorphine Hydrochloride Revenue by Type (2021-2032)
- 4.3.3 Global Buprenorphine Hydrochloride Revenue Market Share by Type (2021-2032)
5 Buprenorphine Hydrochloride Market by Application
- 5.1 Buprenorphine Hydrochloride Application Introduction
- 5.1.1 Analgesic
- 5.1.2 Opioid Antagonist
- 5.2 Global Buprenorphine Hydrochloride Sales by Application
- 5.2.1 Global Buprenorphine Hydrochloride Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Buprenorphine Hydrochloride Sales by Application (2021-2032)
- 5.2.3 Global Buprenorphine Hydrochloride Sales Market Share by Application (2021-2032)
- 5.3 Global Buprenorphine Hydrochloride Revenue by Application
- 5.3.1 Global Buprenorphine Hydrochloride Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Buprenorphine Hydrochloride Revenue by Application (2021-2032)
- 5.3.3 Global Buprenorphine Hydrochloride Revenue Market Share by Application (2021-2032)
6 Global Buprenorphine Hydrochloride Sales by Region
- 6.1 Global Buprenorphine Hydrochloride Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Buprenorphine Hydrochloride Sales by Region (2021-2032)
- 6.2.1 Global Buprenorphine Hydrochloride Sales by Region (2021-2026)
- 6.2.2 Global Buprenorphine Hydrochloride Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Buprenorphine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Buprenorphine Hydrochloride Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Buprenorphine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Buprenorphine Hydrochloride Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Buprenorphine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Buprenorphine Hydrochloride Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Buprenorphine Hydrochloride Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Buprenorphine Hydrochloride Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Buprenorphine Hydrochloride Revenue by Region
- 7.1 Global Buprenorphine Hydrochloride Revenue by Region
- 7.1.1 Global Buprenorphine Hydrochloride Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Buprenorphine Hydrochloride Revenue by Region (2021-2026)
- 7.1.3 Global Buprenorphine Hydrochloride Revenue by Region (2027-2032)
- 7.1.4 Global Buprenorphine Hydrochloride Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Buprenorphine Hydrochloride Revenue (2021-2032)
- 7.2.2 North America Buprenorphine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Buprenorphine Hydrochloride Revenue (2021-2032)
- 7.3.2 Europe Buprenorphine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Buprenorphine Hydrochloride Revenue (2021-2032)
- 7.4.2 Asia-Pacific Buprenorphine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Buprenorphine Hydrochloride Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Buprenorphine Hydrochloride Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Siegfried
- 8.1.1 Siegfried Company Information
- 8.1.2 Siegfried Business Overview
- 8.1.3 Siegfried Buprenorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Siegfried Buprenorphine Hydrochloride Product Portfolio
- 8.1.5 Siegfried Recent Developments
- 8.2 Sanofi
- 8.2.1 Sanofi Company Information
- 8.2.2 Sanofi Business Overview
- 8.2.3 Sanofi Buprenorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sanofi Buprenorphine Hydrochloride Product Portfolio
- 8.2.5 Sanofi Recent Developments
- 8.3 Johnson Matthey
- 8.3.1 Johnson Matthey Company Information
- 8.3.2 Johnson Matthey Business Overview
- 8.3.3 Johnson Matthey Buprenorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Johnson Matthey Buprenorphine Hydrochloride Product Portfolio
- 8.3.5 Johnson Matthey Recent Developments
- 8.4 Mallinckrodt
- 8.4.1 Mallinckrodt Company Information
- 8.4.2 Mallinckrodt Business Overview
- 8.4.3 Mallinckrodt Buprenorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Mallinckrodt Buprenorphine Hydrochloride Product Portfolio
- 8.4.5 Mallinckrodt Recent Developments
- 8.5 Noramco
- 8.5.1 Noramco Company Information
- 8.5.2 Noramco Business Overview
- 8.5.3 Noramco Buprenorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Noramco Buprenorphine Hydrochloride Product Portfolio
- 8.5.5 Noramco Recent Developments
- 8.6 Unichemlabs
- 8.6.1 Unichemlabs Company Information
- 8.6.2 Unichemlabs Business Overview
- 8.6.3 Unichemlabs Buprenorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Unichemlabs Buprenorphine Hydrochloride Product Portfolio
- 8.6.5 Unichemlabs Recent Developments
- 8.7 Arevipharma
- 8.7.1 Arevipharma Company Information
- 8.7.2 Arevipharma Business Overview
- 8.7.3 Arevipharma Buprenorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Arevipharma Buprenorphine Hydrochloride Product Portfolio
- 8.7.5 Arevipharma Recent Developments
- 8.8 Resonance-labs
- 8.8.1 Resonance-labs Company Information
- 8.8.2 Resonance-labs Business Overview
- 8.8.3 Resonance-labs Buprenorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Resonance-labs Buprenorphine Hydrochloride Product Portfolio
- 8.8.5 Resonance-labs Recent Developments
- 8.9 Sun Pharma
- 8.9.1 Sun Pharma Company Information
- 8.9.2 Sun Pharma Business Overview
- 8.9.3 Sun Pharma Buprenorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Sun Pharma Buprenorphine Hydrochloride Product Portfolio
- 8.9.5 Sun Pharma Recent Developments
- 8.10 Rusan Pharma
- 8.10.1 Rusan Pharma Company Information
- 8.10.2 Rusan Pharma Business Overview
- 8.10.3 Rusan Pharma Buprenorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Rusan Pharma Buprenorphine Hydrochloride Product Portfolio
- 8.10.5 Rusan Pharma Recent Developments
- 8.11 Micro Orgo Chem
- 8.11.1 Micro Orgo Chem Company Information
- 8.11.2 Micro Orgo Chem Business Overview
- 8.11.3 Micro Orgo Chem Buprenorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Micro Orgo Chem Buprenorphine Hydrochloride Product Portfolio
- 8.11.5 Micro Orgo Chem Recent Developments
- 8.12 Faranshimi
- 8.12.1 Faranshimi Company Information
- 8.12.2 Faranshimi Business Overview
- 8.12.3 Faranshimi Buprenorphine Hydrochloride Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Faranshimi Buprenorphine Hydrochloride Product Portfolio
- 8.12.5 Faranshimi Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Buprenorphine Hydrochloride Value Chain Analysis
- 9.1.1 Buprenorphine Hydrochloride Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Buprenorphine Hydrochloride Production Mode & Process
- 9.2 Buprenorphine Hydrochloride Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Buprenorphine Hydrochloride Distributors
- 9.2.3 Buprenorphine Hydrochloride Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst